|
|
Article: Investor stand-off threatens Arana takeover.
- Article from:
- Australasian Business Intelligence
- Article date:
- May 11, 2009
CopyrightCOPYRIGHT 2009 News provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Ari Sharp
May 11, 2009 (The Age - ABIX via COMTEX) -- US-based Cephalon has issued a supplementary bidder's statement for its hostile takeover move on fellow pharmaceuticals group Arana Therapeutics. The bid is unchanged at $A1.40 per share in cash, with a premium of $A0.05 if the predator gains more than 90% acceptances. An extension past the deadline of 1 June 2009 has been ruled out ...